IMU 0.00% 4.8¢ imugene limited

Hard to believe?, page-136

  1. 12,712 Posts.
    lightbulb Created with Sketch. 3879
    Had another good read and even if the success percentages aren't as good as the HerVaxx results it is still great for a world first B-cell vaxx. 

    Lesley again and again in her interviews mentioned the importance of trial data, now we got them from 2 vaxx. They will use all their knowledge to make KeyVaxx an even more efficient vaxx.

    It took the big players in the US about 5 years to jump on T-cell, how long will it take to realise that B-cell is more efficient, cheaper, long lasting and saver.

    Time will tell,

    GLTA 
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.